Heron Therapeutics | HRTX - 销售和管理费用

金融业

USD

USD 246.22M

现金及等价物

USD 26.12M

USD 11.12M

USD 228.98M

USD 90.52M

USD 149.65M

股息收益率

0

USD 38K

USD -3.88M

126

EPS每股收益

USD -0.02

股本和储备

USD 9.14M

USD 29.47M

债务利息支出

USD 600K

USD 433K

USD 140.64M

USD 60.1M

USD -2.95M

USD 40.55M

USD 38K

普通股股本

USD 188.31M

USD -2.95M

USD 40.59M

销售和管理费用

USD 23.74M

USD 54.57M

贸易债权人

USD 8.97M

应收帐款人

USD 89.59M

	销售和管理费用	更改		日
ALKERMES	USD 264.59M		77.4M	2026-03
Alnylam Pharmaceuticals	USD 282.51M		2.55M	2026-03
Amarin	USD 18.97M		1.03M	2025-12
ANI Pharmaceuticals	USD 73.66M		9.14M	2026-03
Anika Therapeutics	USD 10.01M		14K	2025-12
Arrowhead Research	USD 41.74M		4.28M	2026-03
Eisai	JPY 119.54B		7.82B	2026-03
Emergent BioSolutions	USD 182.8M		82.3M	2023-06
Esperion Therapeutics	USD 39.42M		456K	2025-12
GlaxoSmithKline	GBP 2.12B		558M	2026-03
Heron Therapeutics	USD 23.74M		605K	2025-12
Insmed	USD 247.26M		34.78M	2026-03
Ligand Pharmaceuticals	USD 20.84M		4.19M	2026-03
Merck	USD 2.67B		180M	2026-03
Nektar Therapeutics	USD 10.17M		10.17M	2025-12
Neurocrine Biosciences	USD 318.5M		16.7M	2026-03
Omeros	USD 11.32M		2.48M	2024-09
Pacira	USD 83.88M		7.99M	2026-03
Regeneron Pharmaceuticals	USD 647.7M		127.3M	2026-03
Roche Holding	CHF 7.28B		3.99B	2025-12
Sangamo BioSciences	USD 9.64M		1.83M	2024-06
Ultragenyx Pharmaceutical	USD 88M		1000K	2026-03
Veracyte	USD 50.84M		7.53M	2026-03
Vertex Pharmaceuticals	USD 493.7M		6.7M	2026-03